SELECTION OF NON-SMALL CELL LUNG CANCER PATIENTS FOR INTERCALATED CHEMOTHERAPY AND TYROSINE KINASE INHIBITORS. Radiology and Oncology, v. 51, n. 3, 10 Sep.2017.